1.
Gadade DD, Pekamwar SS, Shirsat MD. CRYSTAL ENGINEERING OF ANTIVIRAL AGENT EFAVIRENZ FOR SOLUBILITY ENHANCEMENT. J. Drug Delivery Ther. [Internet]. 2018 Jan. 14 [cited 2026 Jun. 25];8(1):86-91. Available from: https://www.jddtonline.info/index.php/jddt/article/view/1637